Showing 1 - 20 results of 99 for search 'M. V. Shestakova', query time: 0.04s Refine Results
  1. 1
    COMMENTS ON GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES ESC-EASD 2007

    COMMENTS ON GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES ESC-EASD 2007 by M. V. Shestakova

    Published 2015-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    On the centenary of the insulin discovery

    On the centenary of the insulin discovery by I. I. Dedov, M. V. Shestakova

    Published 2021-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Practical Applications of Russian DPP4 Inhibitor Gosogliptin in “Palitra” Large-Scale Observational Study

    Practical Applications of Russian DPP4 Inhibitor Gosogliptin in “Palitra” Large-Scale Observational Study by M. V. Shestakova, E. V. Biryukova

    Published 2024-09-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    A COMPREHENSIVE ANALYSIS DIABETES OF RISK FACTORS IN PATIENTS WITH CHRONIC PANCREATITIS

    A COMPREHENSIVE ANALYSIS DIABETES OF RISK FACTORS IN PATIENTS WITH CHRONIC PANCREATITIS by M. A. Kunitsyna, M. V. Shestakova

    Published 2015-10-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Cardiovascular death risk reduction in type 2 diabetes patients with confirmed cardiovascular diseases

    Cardiovascular death risk reduction in type 2 diabetes patients with confirmed cardiovascular diseases by Е. V. Shlyakhto, M. V. Shestakova

    Published 2018-09-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    He is a One-Man Army if he is Dedov

    He is a One-Man Army if he is Dedov by M. V. Shestakova, N. B. Lebedev

    Published 2021-02-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Efficacy and safety of oral semaglutide in Russian patients with type 2 diabetes: subgroup analysis of PIONEER 1, 2, 3 trials

    Efficacy and safety of oral semaglutide in Russian patients with type 2 diabetes: subgroup analysis of PIONEER 1, 2, 3 trials by M. Sh. Shamkhalova, M. V. Shestakova

    Published 2022-07-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    COVID-19 and kidneys

    COVID-19 and kidneys by M. S. Shamkhalova, N. G. Mokrysheva, M. V. Shestakova

    Published 2020-08-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Effects of GLP-1RAs on cardiovascular outcomes in patients with type 2 diabetes mellitus: review of real-world data on target populations from diabetes registry in Russian Federation

    Effects of GLP-1RAs on cardiovascular outcomes in patients with type 2 diabetes mellitus: review of real-world data on target populations from diabetes registry in Russian Federati... by O. K. Vikulova, G. R. Galstyan, M. V. Shestakova

    Published 2022-03-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Assessment of the effectiveness and safety of fixed-dose combination of alogliptin and pioglitazone in real clinical practice: results of the PROsperity study

    Assessment of the effectiveness and safety of fixed-dose combination of alogliptin and pioglitazone in real clinical practice: results of the PROsperity study by M. V. Shestakova, M. I. Kharakhulakh, Y. A. Belolipetsky

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Endothelial dysfunction in patients with obesity and type 2 diabetes mellitus or normoglycemia: assessment of specific markers

    Endothelial dysfunction in patients with obesity and type 2 diabetes mellitus or normoglycemia: assessment of specific markers by E. V. Pokrovskaya, E. A. Shestakova, M. V. Shestakova

    Published 2023-11-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Sodium-glucose cotransporter 2 inhibitors as potential anticancer agents

    Sodium-glucose cotransporter 2 inhibitors as potential anticancer agents by E. R. Radkevich, A. S. Severina, M. S. Shamkhalova, M. V. Shestakova

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    The role of advanced glycation end products in patogenesis of diabetic nephropathy

    The role of advanced glycation end products in patogenesis of diabetic nephropathy by A. O. Gavrilova, A. S. Severina, M. S. Shamhalova, M. V. Shestakova

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Time in range is a tool for assessing the quality of glycemic control in diabetes

    Time in range is a tool for assessing the quality of glycemic control in diabetes by L. A. Suplotova, A. S. Sudnitsyna, N. V. Romanova, M. V. Shestakova

    Published 2021-09-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus

    The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus by O. K. Vikulova, Zamira Zuraeva, L. V. Nikankina, M. V. Shestakova

    Published 2020-08-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Vaccination of patients with diabetes mellitus

    Vaccination of patients with diabetes mellitus by M. V. Shestakova, T. V. Nikonova, V. O. Barysheva, N. G. Mokrysheva

    Published 2022-03-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Tserebrovaskulyarnye zabolevaniya i sakharnyy diabet 2 tipa

    Tserebrovaskulyarnye zabolevaniya i sakharnyy diabet 2 tipa by L. A. Chugunova, P. R. Kamchatnov, A. V. Chugunov, M. V. Shestakova

    Published 2006-03-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Magnetic resonance imaging of the cauda equina in chronic inflammatory demyelinating polyneuropathy

    Magnetic resonance imaging of the cauda equina in chronic inflammatory demyelinating polyneuropathy by A. F. Vasilenko, M. V. Shestakova, I. V. Kochetkov, M. I. Karpova

    Published 2018-01-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Formation of a system of target indicators for rating and integral evaluation of the efficiency of the organization of the provision of medical care to patients with diabetes mellitus in the Russian Federation regions

    Formation of a system of target indicators for rating and integral evaluation of the efficiency of the organization of the provision of medical care to patients with diabetes melli... by I. A. Mikhailov, V. V. Omelyanovsky, M. V. Shestakova, N. G. Mokrysheva

    Published 2022-10-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Prospects for the use of fecal microbiota transplantation in obese patients with Type 2 Diabetes Mellitus for weight loss and improvement of insulin sensitivity

    Prospects for the use of fecal microbiota transplantation in obese patients with Type 2 Diabetes Mellitus for weight loss and improvement of insulin sensitivity by E. V. Pokrovskaya, I. A. Sklyanik, E. A. Shestakova, M. V. Shestakova

    Published 2021-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: